Primary record
4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methyl-butyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid
- 库存
- 9,508 克
- 纯度
- 98.4 %
- CAS
- 1201902-80-8
化合物标识与属性
- CAS
- 1201902-80-8
- PubChem CID
- 49867936
- SMILES
- B1(OC(=O)CC(O1)(CC(=O)O)C(=O)O)[C@H](CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl
- Canonical SMILES
- CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)CC(CC(=O)O)(C(=O)O)O1
名称与同义词
- MLN9708
- Ixazomib citrate
- Nattokinase
- 1201902-80-8
- Ixazomib
- MLN-9708
- Nattokinase?
- Ixazomib Impurity 1
- Ixazomib Impurity 9
- NINLARO
- Ixazomib Citrate (MLN9708)
- MLN 9708
- RefChem:925994
- UNII-E8R04MBQ04
- MFCD18251437
- C20H23BCl2N2O9
- E8R04MBQ04
- 4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid
- CHEMBL1813256
- cc-436
- DTXSID10152721
- orb1306735
- SCHEMBL4415508
- DTXCID7075212
- CTK4B1740
- KS-00000TMU
- MLN9708 (Ixazomib citrate))
- YTXSYWAKVMZICI-PVCZSOGJSA-N
- GLXC-05107
- ixazomib citrate 1,3,2-dioxaborinane
- BYB90280
- EX-A2106
- ABP000733
- BDBM50462621
- NSC758254
- s2181
- 5-(1H-indol-3-yl)-1,3-oxazole
- AKOS015994885
- ACN-041492
- BCP9000957
- CCG-264939
- NSC-758254
- RL00792
- NCGC00249612-01
- NCGC00249612-06
- 133876-92-3
- AC-32721
- AS-75089
- DA-76003
- SY067875
- 4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid
- AB0033792
- A4007
- SW219744-1
- X7548
- A25334
- C71684
- MLN9708,MLN-9708,MLN 9708/
- S-7688
- 1,3,2-Dioxaborinane-4-acetic acid, 4-carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-
- BRD-A66419424-001-02-4
- Q27277012
- 1,3,2-Dioxaborinane-4-acetic acid, 4-carboxy-2-((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-6-oxo-
- 4-(carboxymethyl)-2-[(1R)-1-{2-[(2,5-dichlorophenyl)formamido]acetamido}-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid
- 120191-50-6
- 1239908-20-3
- 4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methyl-butyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid
- 4-(Carboxymethyl)-2-[(1R)-1-{[N-(2,5-dichlorobenzoyl)glycyl]amino}-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid
- 4-(Carboxymethyl)-2-[(R)-1-[2-(2,5-dichlorobenzamido)acetamido]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic Acid
- 4-(r,s)-(carboxymethyl)-2-((r)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid
- 4-(RS)-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic Acid
- 4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid
- MLN-9708; 4-(Carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic Acid